Prescribing Principles

Foundation for Competent Pharmacotherapy

Prescribing principles form the foundation of safe, effective, and legal pharmacotherapy in primary care. For the FNP, mastery of these principles ensures that drug therapy is tailored to the individual patient, minimizes adverse events, and optimizes therapeutic outcomes. This topic is heavily tested on the AANP and ANCC certification exams and is essential for daily clinical decision-making.^[1][2]

Core Pharmacologic Terminology

Pharmacokinetics – What the body does to the drug: absorption, distribution, metabolism, excretion (ADME).
Pharmacodynamics – What the drug does to the body: receptor binding, dose-response, efficacy, potency.
Bioavailability – Fraction of an administered dose that reaches systemic circulation unchanged.
Half-life (t½) – Time required for plasma concentration to decrease by 50%; guides dosing intervals.
Steady state – Achieved after 4–5 half-lives; plasma concentration remains stable with regular dosing.
Therapeutic index – Ratio of toxic dose to effective dose; narrow therapeutic index (e.g., warfarin, digoxin) requires close monitoring.
Loading dose – Higher initial dose to rapidly achieve therapeutic concentration.
Maintenance dose – Dose that keeps plasma concentration at steady state.

Systematic Clinical Prescribing Approach

Step 1: Patient Assessment

Before prescribing, complete a thorough evaluation including age, weight, renal and hepatic function, pregnancy/lactation status, allergies, and current medications (including OTC and supplements). The FNP must also assess the patient’s ability to adhere to the regimen.^[3]

Step 2: Drug Selection

Choose drugs based on efficacy, safety, cost, and patient preference.
Consider evidence-based guidelines (e.g., JNC 8 for hypertension, ADA for diabetes).
Prefer generic formulations when appropriate unless brand is medically necessary (e.g., narrow therapeutic index).
Evaluate drug–drug and drug–disease interactions.

Step 3: Dosing and Regimen

Start at the lowest effective dose (especially in older adults, renal impairment).
Use appropriate dosing intervals based on half-life.
Adjust for organ dysfunction (e.g., creatinine clearance for renally cleared drugs).
Titrate slowly, monitoring therapeutic and adverse effects.
Use loading doses only when rapid onset is necessary (e.g., amiodarone, phenytoin).

Step 4: Monitoring and Follow-Up

Schedule follow-up to assess efficacy, side effects, and adherence.
Order laboratory monitoring as indicated (e.g., INR for warfarin, serum creatinine for ACE inhibitors).
Educate patient on expected onset of action and what to report.
Document rationale for drug selection, dosing, and monitoring plan.

Prescribing for Vulnerable Patient Groups

Pediatrics

Dosing based on weight (mg/kg) or body surface area (BSA).
Many drugs lack pediatric safety data (off-label use is common but requires careful justification).
Avoid drugs with known toxicity (e.g., tetracyclines in children <8 years).

Geriatrics

Use Beer’s Criteria (AGS) to identify potentially inappropriate medications in older adults.^[4]
Start low, go slow – due to reduced hepatic/renal clearance and increased sensitivity.
Monitor for polypharmacy and drug interactions (e.g., anticholinergic burden).

Pregnancy/Lactation

Use FDA pregnancy categories (A, B, C, D, X) – though replaced by the Pregnancy and Lactation Labeling Rule (PLLR), exam still tests categories.
Weigh risk versus benefit; consult LactMed or reputable resources.
Most drugs are excreted in breast milk in small amounts; few are absolutely contraindicated (e.g., methotrexate, radioactive iodine).

Risk Mitigation and Safety Strategies

Adverse drug reactions (ADRs) – Report serious ADRs to FDA MedWatch.
Medication errors – Use the “five rights” (right patient, drug, dose, route, time) and read-back verification.
Controlled substances – Follow state and federal regulations for prescribing (DEA number, prescription monitoring programs).
Antibiotic stewardship – Avoid unnecessary antibiotics; use narrow-spectrum agents when possible.
Black box warnings – Heed FDA boxed warnings (e.g., SSRIs and suicide risk, NSAIDs and CV risk).

Exam-Focused Clinical Pearls and Mnemonics

Know your half-lives: For beta blockers, digoxin, and benzodiazepines – half-life determines dosing frequency.
Narrow therapeutic index drugs: Warfarin, lithium, digoxin, phenytoin, theophylline – require monitoring.
Renal adjustment: For renally cleared drugs (e.g., gabapentin, enoxaparin, metformin) calculate CrCl before dosing.
Drug interactions: CYP450 inducers (e.g., rifampin, phenytoin) reduce drug levels; inhibitors (e.g., fluconazole, erythromycin) increase levels.
Memory aid: “Warfarin, Digoxin, Lithium, Phenytoin, Theophylline” – five narrow TI drugs to automatically check for drug levels.
Prescribing cascade: When a new drug is prescribed for a side effect of another drug – common in older adults.
Shared decision-making: Always discuss risks, benefits, alternatives, and the patient’s treatment goals.

References & Sources

American Nurses Credentialing Center (ANCC). Family Nurse Practitioner (FNP) Certification Exam Blueprint. ANCC; 2023. https://www.nursingworld.org/our-certifications/family-nurse-practitioner/
American Association of Nurse Practitioners (AANP). AANP Certification Exam Blueprint: Family Nurse Practitioner. AANP; 2022. https://www.aanpcert.org/certification/initial
Whalen K, Finkel R, Panavelil TA. Lippincott Illustrated Reviews: Pharmacology. 7th ed. Wolters Kluwer; 2021. https://www.muslimuniversity.edu.af/uploads/library/pharmacology3_532.pdf
American Geriatrics Society (AGS) Beers Criteria® Update Expert Panel. American Geriatrics Society 2023 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2023;71(7):2052-2081. https://doi.org/10.1111/jgs.18372
Woo TM, Robinson MV. Pharmacotherapeutics for Advanced Practice Nurse Prescribers. 5th ed. F.A. Davis; 2020. https://www.fadavis.com/books/pharmacotherapeutics-advanced-practice-nurse-prescribers-5th-edition/
Katzung BG, Vanderah TW. Basic & Clinical Pharmacology. 15th ed. McGraw-Hill; 2021. https://accessmedicine.mhmedical.com/content.aspx?bookid=2988§ionid=250593594
Lehne RA, Moore LA. Pharmacology for Nursing Care. 10th ed. Elsevier; 2019. https://library.kmtc.ac.ke/cgi-bin/koha/opac-detail.pl?biblionumber=5342